A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation
Open accessAbstract
BACKGROUND: Identifying the genetic factors that contribute to memory and learning is limited by the complexity of brain development and the lack of suitable human models for mild disorders of cognition. METHODS: Previously, a disease locus was mapped for a mild type of nonsyndromic mental retardation (IQ between 50 and 70) to a 4.2-MB interval on chromosome 3p25-pter in a large kindred. The genes and transcripts within the candidate region were systematically analyzed for mutations by single-strand polymorphism analysis and DNA sequencing. RESULTS: A nonsense mutation causing a premature stop codon in a novel gene (cereblon; CRBN) was identified that encodes for an ATP-dependent Lon protease. The predicted protein sequence is highly conserved across species, and it belongs to a family of proteins that selectively degrade short-lived polypeptides and regulate mitochondrial replication and transcription. One member of the Lon-containing protein family is regionally expressed in the human hippocampus, an important neuroanatomic region that is involved in long-term potentiation and learning. The mutation in the CRBN gene described interrupts an N-myristoylation site and eliminates a casein kinase II phosphorylation site at the C terminus. CONCLUSIONS: A gene on chromosome 3p that is associated with mild mental retardation in a large kindred is reported. This finding implicates a role for the ATP-dependent degradation of proteins in memory and learning.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A number of endogenous CRBN-interacting proteins have been reported, including MEIS2, AMPK, MCT1, and GS17.
“A number of endogenous CRBN-interacting proteins have been reported, including MEIS2, AMPK, MCT1, and GS17,170–172”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [172]
Some endogenous CRBN-interacting proteins compete with thalidomide analogue-targeted neosubstrates for CRL4CRBN-dependent ubiquitination and degradation.
“some of which compete with thalidomide analogue-targeted neosubstrates for CRL4CRBN-dependent ubiquitination and degradation.”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [172]
The citation lists haven’t been fetched yet
References 35 · Cited by 250
- Authors
- Higgins, J. J., Pucilowska, J., Lombardi, R. Q., & Rooney, J. P.
- Affiliations
- From the Center for Human Genetics and Child Neurology, Mid-Hudson Family Health Institute, New Paltz, NY.
- Venue
- Neurology
- Published
- 2004-11-23
- Volume
- 63
- Issue
- 10
- Pages
- 1927-1931
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC1201536
- OpenAlex
- W2119601553
- Cited by
- 250
- References
- 35
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 12 · 2023: 10 · 2022: 12 · 2021: 20 · 2020: 17 · 2019: 10 · 2018: 19 · 2017: 8 · 2016: 16 · 2015: 16 · 2014: 15 · 2013: 7 · 2012: 6
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01ns042422-04)
- National Institute of Neurological Disorders and Stroke (R01 NS042422, R01 NS 42422, R01 NS042422-04)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- Lon protease, cereblon, nonsense mutation, mild intellectual disability, chromosome 3p, N-myristoylation, casein kinase II phosphorylation, protein degradation, hippocampus, learning and memory, familial kindred
- MeSH terms
- Amino Acid Sequence, Chromosomes, Human, Pair 3, Consanguinity, Exons, Female, Humans, Learning Disabilities, Male, Memory Disorders, Intellectual Disability, Molecular Sequence Data, Nerve Tissue Proteins, Pedigree, Peptide Hydrolases, Phenotype, Phosphorylation, Protein Processing, Post-Translational, Polymerase Chain Reaction, Consensus Sequence, Sequence Alignment, Sequence Homology, Amino Acid, Codon, Nonsense, Founder Effect, Polymorphism, Single-Stranded Conformational, Myristic Acid, Ubiquitin-Protein Ligases, Casein Kinase II, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review